Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 6, 2009, Pages

  Basu, Kaninika ^a,b   Palmer, Colin N A ^c   Tavendale, Roger ^c   Lipworth, Brian J ^c   Mukhopadhyay, Somnath ^a,b  

^a ROYAL ALEXANDRA CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

adrenergic 2 receptor agonist gene; albuterol; Asthma; asthma exacerbations; child; polymorphism; salmeterol; 2 adrenoceptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL; SALMETEROL; STEROID;

ADOLESCENT; ADRB2 GENE; ADULT; ARTICLE; ASTHMA; CHILD; DISEASE EXACERBATION; FEMALE; GENE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 71249116882     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.043     Document Type: Article

References (40)

1. Deen J.L., Vos T., Huttly S.R., and Tulloch J. Injuries and noncommunicable diseases: emerging health problems of children in developing countries. Bull World Health Org 77 (1999) 518-524
2. Fuhlbrigge A.L., Adams R.J., Guilbert T.W., Grant E., Lozano P., Janson S.L., et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 166 (2002) 1044-1049
3. British Guideline on the Management of Asthma. British Thoracic Society Scottish Intercollegiate Guidelines Network. Thorax 63 (2008) iv1-121
4. Jindal S.K., Gupta D., Aggarwal A.N., and Agarwal R. Guidelines for management of asthma at primary and secondary levels of health care in India (2005) [A Consensus Statement Developed under the World Health Organization and Government of India Collaborative Programme (2004-2005)]. Indian J Chest Dis Allied Sci 47 (2005) 309-343
5. National Institutes of Health, National Heart, Lung, and Blood Institute. Global strategy for asthma management and prevention (2002), National Institutes of Health, Bethesda
6. Rachelefsky G.S., Shapiro G.G., Bergman D., and Blessing-Moore J. Pediatric asthma: promoting best practice. Guide for Managing Asthma in Children (1999), American Academy of Allergy, Asthma & Immunology, Rochester (NY)
7. Palmer C.N.A., Lipworth B.J., Lee S., Ismail T., Macgregor D.F., and Mukhopadhyay S. Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 61 (2006) 940-944
8. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
9. Hancox R.J., Sears M.R., and Taylor D.R. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma. Eur Respir J 11 (1998) 589-593
10. Israel E., Chinchilli V., Ford J., Boushey H., Cherniack R., Craig T., et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 (2004) 1505-1512
11. Israel E., Drazen J., Liggett S., Boushey H., Cherniack R., Chinchilli V., et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 162 (2000) 75-80
12. Taylor D., Drazen J., Herbison G., Yandava C., Hancox R., and Town G. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 55 (2000) 762-767
13. Holgate S.T. Exacerbations-the asthma paradox. Am J Respir Crit Care Med 172 (2005) 941-942
14. Milton B., Whitehead M., Holland P., and Hamilton V. The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child Care Health Dev 30 (2004) 711-728
15. Dawson K.P., Jandera E., and Penna A.C. The prehospital management of children with acute asthma. J Paediatr Child Health 28 (1992) 321-322
16. Flores G., Abreu M., Tomany-Korman S., and Meurer J. Keeping children with asthma out of hospitals: parents' and physicians' perspectives on how pediatric asthma hospitalizations can be prevented. Pediatrics 116 (2005) 957-965
17. Palmer C., Ismail T., Lee S., Terron- Kwiatkowski A., Zhao Y., Liao H., et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 120 (2007) 64-68
18. Palmer C.N.A., Doney A.S., Ismail T., Lee S.P., Murrie I., Macgregor D.F., et al. PPARG locus haplotype variation and exacerbations in asthma. Clin Pharmacol Ther 81 (2007) 13-18
19. Tavendale R., Macgregor D.F., Mukhopadhyay S., and Palmer C.N. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol 121 (2008) 860-863
20. Basu K., Palmer C.N.A., Lipworth B.J., McLean W.H.I., Terron-Kwiatkowski A., Zhao Y., et al. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 63 (2008) 1211-1217
21. Palmer C.N.A., Doney A.S., Lee S.P., Murrie I., Ismail T., Macgregor D.F., et al. Glutathione-S-transferase M1 and P1 genotype, passive smoking and peak expiratory flow in asthma. Pediatrics 118 (2006) 710-716
22. Palmer C.N.A., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
23. Bieche I., Olivi M., Champeme M.H., Vidaud D., Lidereau R., and Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 78 (1998) 661-666
24. Lee D.K., Jackson C.M., Currie G.P., Cockburn W.J., and Lipworth B.J. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. Br J Clin Pharmacol 56 (2003) 494-500
25. Hall I.P., Blakey J.D., Al Balushi K.A., Wheatley A., Sayers I., Pembrey M.E., et al. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Lancet 368 (2006) 771-779
26. Drysdale C., McGraw D., Stack C., Stephens J., Judson R., Nandabalan K., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97 (2000) 10483-10488
27. Martinez F.D., Graves P.E., Baldini M., Solomon S., and Erickson R. Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100 (1997) 3184-3188
28. Taylor D.A., Jensen M.W., Aikman S.L., Harris J.G., Barnes P.J., and O'Connor B.J. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am J Respir Crit Care Med 156 (1997) 1731-1737
29. Currie G.P., Lee D.K., Haggart K., Bates C.E., and Lipworth B.J. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 167 (2003) 1232-1238
30. Bleecker E.R., Postma D.S., Lawrance R.M., Meyers D.A., Ambrose H.J., and Goldman M. Effect of ADRB2 polymorphisms on response to long-acting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 370 (2007) 2118-2125
31. Mitra A.D., Ogston S., Crighton A., and Mukhopadhyay S. Lung function and asthma symptoms in children: relationships and response to treatment. Acta Paediatr 91 (2002) 789-792
32. Korppi M., and Remes K. Asthma treatment in schoolchildren: lung function in different therapeutic groups. Acta Paediatr 85 (1996) 190-194
33. Piippo-Savolainen E., Remes S., Kannisto S., Korhonen K., and Korppi M. Early predictors for adult asthma and lung function abnormalities in infants hospitalized for bronchiolitis: a prospective 18- to 20-year follow-up. Allergy Asthma Proc 27 (2006) 341-349
34. Wechsler M., Lehman E., Lazarus S., Lemanske Jr. R., Boushey H., Deykin A., et al. beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 173 (2006) 519-526
35. Piippo-Savolainen E., and Korppi M. Wheezy babies-wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing. Acta Paediatr 97 (2008) 5-11
36. Korppi M., Kuikka L., Reijonen T., Remes K., Juntunen-Backman K., and Launiala K. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med 148 (1994) 1079-1084
37. Hyvärinen M., Piippo-Savolainen E., Korhonen K., and Korppi M. Teenage asthma after severe infantile bronchiolitis or pneumonia. Acta Paediatr 94 (2005) 1378-1383
38. Kotaniemi-Syrjänen A., Reijonen T.M., Korhonen K., and Korppi M. Wheezing requiring hospitalization in early childhood: predictive factors for asthma in a six-year follow-up. Pediatr Allergy Immunol 13 (2002) 418-425
39. Stein R.T., Holberg C.J., Sherrill D., Wright A.L., Morgan W.J., Taussig L., et al. Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study. Am J Epidemiol 149 (1999) 1030-1037
40. O'Connor B.J., Aikman S.L., and Barnes P.J. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med 327 (1992) 1204-1208